Skeletal Muscle Nuclei in Mice are not Post-mitotic

Agnieszka K Borowik1, Arik Davidyan1,2, Frederick F Peelor1

  • 1Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, 825 NE 13th St, Oklahoma City, OK 73104, USA.

Function (Oxford, England)
|December 26, 2022
PubMed

Insights

Skeletal muscle nuclei, previously thought unable to divide, can replicate in vivo. This discovery challenges existing dogma and suggests new ways to promote muscle repair and growth.

Area of Science:

  • Skeletal Muscle Physiology
  • Cell Biology
  • Molecular Biology

Background:

  • The prevailing view in skeletal muscle research is that myonuclei are post-mitotic and lack proliferative capacity.
  • Recent deuterium oxide (D2O) labeling studies indicated DNA synthesis within skeletal muscle tissue.

Purpose of the Study:

  • To investigate the hypothesis that resident myonuclei possess the ability to replicate in vivo.
  • To challenge the established dogma of post-mitotic myonuclei in skeletal muscle.

Main Methods:

  • Utilized a mouse model with temporal myonuclear labeling using Green Fluorescent Protein (GFP).
  • Administered D2O labeling during normal cage activity, functional overload, and satellite cell ablation.
  • Quantified DNA synthesis via fractional synthesis rates (FSR) in various skeletal muscles.

Main Results:

  • Observed deuterium enrichment in myonuclear DNA across multiple skeletal muscles (Plantaris, Tibialis Anterior, Gastrocnemius, Quadriceps) during normal activity.
  • Calculated significant fractional synthesis rates (FSR) for DNA in myonuclei, indicating replication.
  • Replication rates were largely consistent across experimental conditions, with increased synthesis in overloaded Plantaris muscle.
  • Provided evidence that myonuclear replication occurs via endoreplication, leading to polyploidy.

Conclusions:

  • Demonstrated that myonuclei in skeletal muscle fibers can replicate in vivo, contradicting the long-held belief of their post-mitotic nature.
  • These findings suggest novel therapeutic strategies for muscle maintenance and hypertrophy by leveraging the intrinsic replicative potential of myonuclei.